Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.

Gonzalo-Gil E, Ikediobi U, Sutton RE.

Yale J Biol Med. 2017 Jun 23;90(2):245-259. eCollection 2017 Jun. Review.

2.

Effect of Korean Red Ginseng intake on the survival duration of human immunodeficiency virus type 1 patients.

Cho YK, Kim JE.

J Ginseng Res. 2017 Apr;41(2):222-226. doi: 10.1016/j.jgr.2016.12.006. Epub 2017 Jan 6.

3.

Preservation affinity in consensus modules among stages of HIV-1 progression.

Mosaddek Hossain SM, Ray S, Mukhopadhyay A.

BMC Bioinformatics. 2017 Mar 20;18(1):181. doi: 10.1186/s12859-017-1590-3.

4.

Personalized life expectancy and treatment benefit index of antiretroviral therapy.

Xiao Y, Sun X, Tang S, Zhou Y, Peng Z, Wu J, Wang N.

Theor Biol Med Model. 2017 Jan 18;14(1):1. doi: 10.1186/s12976-016-0047-0.

5.

Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.

Mudd JC, Brenchley JM.

J Infect Dis. 2016 Oct 1;214 Suppl 2:S58-66. doi: 10.1093/infdis/jiw258.

PMID:
27625432
6.

Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ T-cells Over Time.

Paintsil E, Martin R, Goldenthal A, Bhandari S, Andiman W, Ghebremichael M.

J AIDS Clin Res. 2016 Apr;7(4). pii: 565. Epub 2016 Apr 14.

7.

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death.

Olson AD, Walker AS, Suthar AB, Sabin C, Bucher HC, Jarrin I, Moreno S, Perez-Hoyos S, Porter K, Ford D; CASCADE Collaboration in EuroCoord.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):100-8. doi: 10.1097/QAI.0000000000001029.

8.

Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals.

Wang S, Hottz P, Schechter M, Rong L.

PLoS Comput Biol. 2015 Dec 28;11(12):e1004665. doi: 10.1371/journal.pcbi.1004665. eCollection 2015 Dec.

9.

Changes in B-Cell Counts and Percentages during Primary HIV Infection Associated with Disease Progression in HIV-Infected Men Who Have Sex with Men: A Preliminary Study.

Cui C, Jiang Y, Zhang Z, Hu Q, Chu Z, Xu J, Zhao B, Ding H, Liu J, Han X, Cao Y, Shang H.

Biomed Res Int. 2015;2015:468194. doi: 10.1155/2015/468194. Epub 2015 Sep 7.

10.

Late presentation to HIV testing is overestimated when based on the consensus definition.

Sasse A, Florence E, Pharris A, De Wit S, Lacor P, Van Beckhoven D, Deblonde J, Delforge ML, Fransen K, Goffard JC, Legrand JC, Moutschen M, Piérard D, Ruelle J, Vaira D, Vandercam B, Van Ranst M, Van Wijngaerden E, Vandekerckhove L, Verhofstede C; Belgian Research AIDS & HIV Consortium (BREACH).

HIV Med. 2016 Mar;17(3):231-4. doi: 10.1111/hiv.12292. Epub 2015 Jul 28.

11.

Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells.

Cummins NW, Sainski AM, Natesampillai S, Bren GD, Badley AD.

Mol Cell Ther. 2014 Jan 3;2:1. doi: 10.1186/2052-8426-2-1. eCollection 2014.

12.

The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model.

Lima VD, Graf I, Beckwith CG, Springer S, Altice FL, Coombs D, Kim B, Messina L, Montaner JS, Spaulding A.

PLoS One. 2015 Apr 23;10(4):e0123482. doi: 10.1371/journal.pone.0123482. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128734. Kim, Brian [corrected to Kim, Bryan].

13.

Polymorphisms in the IFNγ, IL-10, and TGFβ genes may be associated with HIV-1 infection.

Freitas FB, Lima SS, Feitosa RN, Azevedo VN, Ishak Mde O, Ishak R, Vallinoto AC.

Dis Markers. 2015;2015:248571. doi: 10.1155/2015/248571. Epub 2015 Feb 24.

14.
15.

A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.

Savkovic B, Nichols J, Birkett D, Applegate T, Ledger S, Symonds G, Murray JM.

PLoS Comput Biol. 2014 Jun 19;10(6):e1003681. doi: 10.1371/journal.pcbi.1003681. eCollection 2014 Jun.

16.

Glutathione synthesis is compromised in erythrocytes from individuals with HIV.

Morris D, Ly J, Chi PT, Daliva J, Nguyen T, Soofer C, Chen YC, Lagman M, Venketaraman V.

Front Pharmacol. 2014 Apr 11;5:73. doi: 10.3389/fphar.2014.00073. eCollection 2014.

17.

A stochastic multi-scale model of HIV-1 transmission for decision-making: application to a MSM population.

Yeghiazarian L, Cumberland WG, Yang OO.

PLoS One. 2013 Nov 26;8(11):e70578. doi: 10.1371/journal.pone.0070578. eCollection 2013.

18.

Mucosal immunology of HIV infection.

Xu H, Wang X, Veazey RS.

Immunol Rev. 2013 Jul;254(1):10-33. doi: 10.1111/imr.12072. Review.

19.

Modelling the course of an HIV infection: insights from ecology and evolution.

Alizon S, Magnus C.

Viruses. 2012 Oct 4;4(10):1984-2013. doi: 10.3390/v4101984. Review.

20.

Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice.

Hur EM, Patel SN, Shimizu S, Rao DS, Gnanapragasam PN, An DS, Yang L, Baltimore D.

Blood. 2012 Nov 29;120(23):4571-82. doi: 10.1182/blood-2012-04-422303. Epub 2012 Oct 11.

Supplemental Content

Support Center